(Inclusive of all taxes)
Pneumovax 23 Vaccine 0.5ml is a vaccine that protects against different types of streptococcus pneumoniae bacteria that can cause serious infections such as pneumonia, meningitis, sepsis, blood infections, and ear infections. Pneumovax 23 is recommended for children and adults at high risk of pneumococcal infections. Pneumovax 23 Vaccine helps the body make its own antibodies that protect you from these diseases. Pneumovax 23 Vaccine 0.5ml protects only against diseases caused by the thirteen strains of streptococcus pneumoniae contained in the vaccine.
Pneumovax 23 Vaccine should be administered intramuscularly, usually in the muscle of the upper arm. Pneumovax 23 Vaccine should not be self-administered. It is important that you receive all the doses of this Pneumovax 23 Vaccine 0.5ml to make it effective.
Pneumovax 23 may cause some side effects, although not everyone experiences them. Some of the most common side effects include reactions at the injection site, such as pain, swelling, or redness, as well as irritability, loss of appetite, and sleepiness. These side effects are usually mild and go away on their own within a few days. If you experience any of these side effects and they persist or get worse, it is important to let your doctor know. Your doctor may be able to recommend ways to reduce or prevent these symptoms.
You should not receive a booster dose of this Pneumovax 23 Vaccine if you had a life-threatening allergic reaction after the first shot.
Before taking Pneumovax 23 Vaccine if you ever had a severe allergic reaction to a pneumococcal or diphtheria toxoid vaccine or a bleeding or blood clotting disorder such as haemophilia or easy bruising or a weak immune system (caused by disease or by using certain medicine). You should also tell the doctor about all the medicines you are taking. Pregnant and breastfeeding mothers should consult and seek advice from their doctor before receiving the Pneumovax 23.
Pneumovax 23 Vaccine is not recommended for use in children less than 2 years of age. Safety and effectiveness in children below the age of 2 years have not been established.
Pneumovax 23 Vaccine 0.5ml will not prevent disease caused by capsular types of pneumococcus other than those contained in the vaccine.
Pneumovax 23 Vaccine to prevent different types of streptococcus pneumoniae bacteria that can cause serious infections such as pneumonia, meningitis, sepsis, blood infections, and ear infections in children and adults.
Use of Pneumovax 23 Vaccine 0.5ml has several benefits in protecting against different types of streptococcus pneumoniae bacteria, which can cause serious infections such as pneumonia, meningitis, and sepsis.
Pneumovax 23 Vaccine is highly effective in preventing pneumococcal pneumonia, which is a serious lung infection caused by Streptococcus pneumoniae bacteria. Pneumovax 23 Vaccine 0.5ml also reduces the need for hospitalization and death caused by pneumococcal pneumonia.
Pneumovax 23 also protects against other invasive infections caused by the bacteria, such as meningitis, sepsis, and bacteremia.
Pneumovax 23 Vaccine is recommended for children, adults at high risk of pneumococcal infection, and older adults. It is particularly important for individuals who are more likely to develop severe illness or complications from pneumococcal infections.
Pneumovax 23 Vaccine 0.5ml can also provide herd immunity, meaning that when enough people in a community are vaccinated, the spread of the bacteria is less likely, ultimately protecting the unvaccinated people as well.
Pneumovax 23 is cost-effective as it helps prevent serious illnesses and hospitalizations, which can be expensive to treat.
Like all medications, Pneumovax 23 Vaccine 0.5ml can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Pneumovax 23 Vaccine is administered by a healthcare professional or nurse in a hospital or clinic setting. The specific dosing and administration of Pneumovax 23 will depend on the clinical condition of the patient's age and medical history, and other factors. Kindly do not self-administer.
Pneumovax 23 Vaccine 0.5ml works by introducing a small piece of the pneumococcal bacteria, called a polysaccharide, into the body. The polysaccharide is attached or conjugated, to a protein that helps the immune system recognize it as foreign. This prompts the immune system to produce antibodies against the polysaccharide, which can protect against future infections with the bacteria. Pneumovax 23 Vaccine is designed to protect against 13 different types of pneumococcal bacteria, which are responsible for many cases of pneumonia, meningitis, and other serious infections.
It is not known whether this Pneumovax 23 Vaccine 0.5ml is excreted in human milk. Caution should be exercised when Pneumovax 23 Vaccine is administered to a nursing mother.
It is generally not recommended to drink alcohol while taking Pneumovax 23 Vaccine. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
Pneumovax 23 Vaccine 0.5ml is unlikely to affect your ability to drive or operate machinery. If you experience any side effects while taking Pneumovax 23 Vaccine such as dizziness or drowsiness, it is important to avoid driving or operating heavy machinery until the side effects have resolved.
Pneumovax 23 should be used with caution in patients with Kidney disease. It is important that patients with kidney disease closely monitor kidney function while taking Pneumovax 23 Vaccine 0.5ml and report any unusual symptoms or changes in kidney function to their doctor. The dose of Pneumovax 23 may need to be adjusted in patients with kidney disease.
Pneumovax 23 Vaccine should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Pneumovax 23 and report any unusual symptoms or changes in liver function to their doctor. The dose of Pneumovax 23 may need to be adjusted in patients with liver disease.
Animal reproduction studies have not been conducted with Pneumovax 23 Vaccine 0.5ml. It is not known whether Pneumovax 23 Vaccine can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Pneumovax 23 Vaccine 0.5ml should be given to pregnant women only if clearly needed.
1. InjectionPNEUMOVAX 23(pneumococcal vaccine, polyvalent, MSD), MSD (Thailand) Ltd. / Merck Sharp & Dohme Corp., West Point, Pennsylvania 19486, USA, Product Leaflet
2. PNEUMOVAX 23- pneumococcal vaccine polyvalent injection, solution, Merck Sharp & Dohme LLC, Product Leaflet
3. Injection Pneumovax 23 (pneumococcal Vaccine, Polyvalent, Msd), Merck Sharp & Dohme (Malaysia) Sdn. Bhd. Product Leaflet
4. Patient Information about PNEUMOVAX 23 (pronounced noo-mo-vax 23) Generic Name: pneumococcal vaccine polyvalent, Merck & Co. Inc. USA, Product Leaflet